0001127602-20-024721.txt : 20200903
0001127602-20-024721.hdr.sgml : 20200903
20200903171755
ACCESSION NUMBER: 0001127602-20-024721
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200901
FILED AS OF DATE: 20200903
DATE AS OF CHANGE: 20200903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCDONNELL MICHAEL R
CENTRAL INDEX KEY: 0001121897
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19311
FILM NUMBER: 201159978
MAIL ADDRESS:
STREET 1: C/O IQVIA HOLDINGS INC.
STREET 2: 83 WOOSTER HEIGHTS ROAD
CITY: DANBURY
STATE: CT
ZIP: 06810
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOGEN INC.
CENTRAL INDEX KEY: 0000875045
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330112644
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 225 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 7814642000
MAIL ADDRESS:
STREET 1: 225 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: BIOGEN IDEC INC.
DATE OF NAME CHANGE: 20070427
FORMER COMPANY:
FORMER CONFORMED NAME: BIOGEN IDEC INC
DATE OF NAME CHANGE: 20031112
FORMER COMPANY:
FORMER CONFORMED NAME: IDEC PHARMACEUTICALS CORP / DE
DATE OF NAME CHANGE: 19970530
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-09-01
0000875045
BIOGEN INC.
BIIB
0001121897
MCDONNELL MICHAEL R
225 BINNEY STREET
CAMBRIDGE
MA
02142
1
EVP, Chief Financial Officer
Restricted Stock Unit
0
2020-09-01
4
A
0
8045
0
A
2023-09-01
Common Stock
8045
8045
D
Restricted Stock Unit
0
2020-09-01
4
A
0
16090
0
A
2023-09-01
Common Stock
16090
16090
D
The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 09/01/2020.
The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average closing stock price for the 30 calendar days following and including the grant date and 30 calendar days prior to and including such vesting date]).
/s/ Suzanne Murray, Attorney in Fact for Michael R. McDonnell
2020-09-03